Guardian Pharmacy Services (GRDN) EBITDA (2023 - 2026)

Guardian Pharmacy Services (GRDN) has 4 years of EBITDA data on file, last reported at $17.7 million in Q1 2026.

• Quarterly EBITDA rose 35.91% year-over-year to $17.7 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $77.4 million (up 233.75% YoY) and the FY2025 annual result came in at $72.7 million, up 215.55% from the prior year.
• EBITDA fell to $17.7 million in Q1 2026 per GRDN's latest filing, from $30.8 million in the prior quarter.
• The five-year high for EBITDA was $30.8 million in Q4 2025, with the low at -$104.6 million in Q3 2024.
• Average EBITDA over 4 years is $3.3 million, with a median of $15.5 million recorded in 2023.
• Year-over-year, EBITDA sank 1552.65% in 2024 and soared 115.63% in 2025.
• Guardian Pharmacy Services' EBITDA stood at $15.5 million in 2023, then increased by 7.93% to $16.8 million in 2024, then surged by 83.6% to $30.8 million in 2025, then slumped by 42.54% to $17.7 million in 2026.
• Business Quant data shows GRDN's EBITDA at $17.7 million in Q1 2026, $30.8 million in Q4 2025, and $16.4 million in Q3 2025.